Metric Finance
LearnFAQ
LearnFAQ

Learn / ASMB

NASDAQ: ASMB

Assembly Biosciences (ASMB) stock, explained like you're 5

Assembly Biosciences trades on the Nasdaq under the ticker ASMB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 479 million dollars.

Ticker
ASMB
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 479 million dollars

Is Assembly Biosciences a small, medium or large cap company?

No. Assembly Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 479 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Assembly Biosciences makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ASMB stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • ASMB Nov 2026 35.000 call (ASMB261120C00035000) stock price, news, quote and history (Yahoo Finance UK)
  • (ASMB) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
  • ASMB Forecast Price Target Prediction for 2027 (TradingView)
  • No serious health problems were reported at tested doses of an experimental liver drug (Stock Titan)
  • ASMB Dec 2026 50.000 call (ASMB261218C00050000) Stock Price, News, Quote & History (Yahoo! Finance Canada)

Follow ASMB in your daily brief

Each trading day at 5 PM ET we post what happened to Assembly Biosciences and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ASMB

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Assembly Biosciences stock

What does Assembly Biosciences do?

Assembly Biosciences trades on the Nasdaq under the ticker ASMB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 479 million dollars.

What is the ticker symbol for Assembly Biosciences?

Assembly Biosciences trades under the ticker ASMB on the Nasdaq.

What is Assembly Biosciences's market cap?

Assembly Biosciences is a small cap stock with a market cap of about 479 million dollars.

How does Assembly Biosciences make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ASMB stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ASMB stock every day?

Add ASMB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ASMB daily

A free brief on Assembly Biosciences and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ASMB: ASMB vs NVS, ASMB vs AZN, ASMB vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed